{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:20:05Z","timestamp":1791811205537,"version":"4.3.4"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bpobgyn.2023.102391","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T06:18:51Z","timestamp":1689142731000},"page":"102391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Robotic surgery in ovarian cancer"],"prefix":"10.1016","volume":"90","author":[{"given":"Valerio","family":"Gallotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Certelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rosati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Loverro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Lodoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazario","family":"Foschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Lathouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2023.102391_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102391_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/uog.23635","article-title":"ESGO\/ISUOG\/IOTA\/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors","volume":"58","author":"Timmerman","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102391_bib4","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jmig.2017.12.023","article-title":"Role of intraoperative ultrasound to extend the application of minimally invasive surgery for treatment of recurrent gynecological cancer","volume":"25","author":"Mascilini","year":"2018","journal-title":"J\u00a0Minim Invasive Gynecol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2023.102391_bib5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11547-020-01170-6","article-title":"Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival","volume":"125","author":"Avesani","year":"2020","journal-title":"Radiol Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102391_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","article-title":"Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features","volume":"460","author":"Prat","year":"2012","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102391_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2018.08.016","article-title":"Histotype classification of ovarian carcinoma: a comparison of approaches","volume":"151","author":"Peres","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib8","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.2147\/OTT.S102569","article-title":"Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer","volume":"10","author":"Hollis","year":"2017","journal-title":"OncoTargets Ther"},{"issue":"14","key":"10.1016\/j.bpobgyn.2023.102391_bib9","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2006.03.025","article-title":"Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations","volume":"42","author":"Ferrandina","year":"2006","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.bpobgyn.2023.102391_bib10","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1245\/s10434-017-6005-1","article-title":"Hepatoceliac lymph node involvement in advanced ovarian cancer patients: prognostic role and clinical considerations","volume":"24","author":"Gallotta","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102391_bib11","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1245\/s10434-014-3558-0","article-title":"Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: prognostic role and clinical considerations","volume":"21","author":"Gallotta","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"26","key":"10.1016\/j.bpobgyn.2023.102391_bib12","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.bpobgyn.2023.102391_bib13","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","article-title":"Niraparib in patients with newly diagnosed advanced ovarian cancer","volume":"381","author":"Gonz\u00e1lez-Mart\u00edn","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2019-000308","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","author":"Colombo","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102391_bib16","doi-asserted-by":"crossref","first-page":"642.e1","DOI":"10.1016\/j.ajog.2008.06.052","article-title":"Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma","volume":"199","author":"Fagotti","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2023.102391_bib17","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/ijgc-2020-001584","article-title":"Laparoscopic cytoreduction after neoadjuvant ChEmotherapy (LANCE)","volume":"30","author":"Nitecki","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102391_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","article-title":"Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European organisation for research and treatment of cancer-adjuvant ChemoTherapy in ovarian neoplasm trial","volume":"95","author":"Trimbos","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"13","key":"10.1016\/j.bpobgyn.2023.102391_bib19","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/jnci\/djq149","article-title":"Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial","volume":"102","author":"Trimbos","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102391_bib20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ygyno.2021.04.007","article-title":"The attributive value of comprehensive surgical staging in clinically early-stage epithelial ovarian carcinoma: a systematic review and meta-analysis","volume":"161","author":"Van De Vorst","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102391_bib21","doi-asserted-by":"crossref","first-page":"769e74","DOI":"10.1016\/j.jmig.2016.03.006","article-title":"Laparoscopic versus laparotomic surgical staging for early-stage ovarian cancer: a case-control study","volume":"23","author":"Gallotta","year":"2016","journal-title":"J\u00a0Minim Invasive Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102391_bib22","doi-asserted-by":"crossref","first-page":"428e34","DOI":"10.1016\/j.ygyno.2014.09.006","article-title":"Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series","volume":"135","author":"Gallotta","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102391_bib23","doi-asserted-by":"crossref","first-page":"2012e9","DOI":"10.1245\/s10434-008-9893-2","article-title":"Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer","volume":"15","author":"Park","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102391_bib24","doi-asserted-by":"crossref","first-page":"1614e9","DOI":"10.1016\/j.ajog.2004.11.018","article-title":"The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers","volume":"192","author":"Chi","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102391_bib25","doi-asserted-by":"crossref","first-page":"754e65","DOI":"10.1016\/j.jmig.2013.04.027","article-title":"Role of minimally invasive surgery in ovarian cancer","volume":"20","author":"Nezhat","year":"2013","journal-title":"J\u00a0Minim Invasive Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102391_bib26","doi-asserted-by":"crossref","first-page":"474.e1","DOI":"10.1016\/j.ajog.2019.10.104","article-title":"Survival outcomes for robotic-assisted laparoscopy versus traditional laparoscopy in clinical stage I epithelial ovarian cancer","volume":"222","author":"Facer","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102391_bib27","doi-asserted-by":"crossref","first-page":"552e62","DOI":"10.1016\/j.jmig.2017.02.013","article-title":"Minimally invasive surgical staging in early-stage ovarian carcinoma: a systematic review and metaanalysis","volume":"24","author":"Bogani","year":"2017","journal-title":"J\u00a0Minim Invasive Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102391_bib28","first-page":"111e7","article-title":"Comparison of laparoscopy and laparotomy for the management of early-stage ovarian cancer: surgical and oncologica outcomes","volume":"25","author":"Koo","year":"2014","journal-title":"J\u00a0Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102391_bib29","doi-asserted-by":"crossref","first-page":"352e7","DOI":"10.1097\/IGC.0000000000000033","article-title":"Comparison of laparoscopy and laparotomy in the surgical management of early-stage ovarian cancer","volume":"24","author":"Liu","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102391_bib30","doi-asserted-by":"crossref","first-page":"461e5","DOI":"10.1016\/j.ygyno.2016.03.030","article-title":"Laparoscopic fertility-sparing surgery for early ovarian epithelial cancer: a multi-institutional experience","volume":"141","author":"Ghezzi","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102391_bib31","first-page":"CD005344","article-title":"Laparoscopy versus laparotomy for FIGO stage I ovarian cancer","author":"Lawrie","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102391_bib32","doi-asserted-by":"crossref","first-page":"50.e1","DOI":"10.1016\/j.ajog.2016.08.030","article-title":"Laparoscopic staging for apparent stage I epithelial ovarian cancer","volume":"216","author":"Melamed","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102391_bib33","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.ejso.2021.01.033","article-title":"Minimally invasive surgical staging for early stage ovarian cancer: a long-term follow up","volume":"47","author":"Gallotta","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102391_bib34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00404-016-4087-9","article-title":"Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer:a retrospective, multicenter analysis","volume":"294","author":"Bellia","year":"2016","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102391_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jmig.2016.11.004","article-title":"Robotic versus laparoscopic staging for early ovarian cancer: a case matched control study","volume":"24","author":"Gallotta","year":"2017","journal-title":"J\u00a0Minim Invasive Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102391_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ygyno.2010.11.045","article-title":"Robotic approach for ovarian cancer: perioperative and survival results and comparison with laparoscopy and laparotomy","volume":"121","author":"Magrina","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102391_bib37","doi-asserted-by":"crossref","first-page":"324.e1","DOI":"10.1016\/j.ajog.2019.05.005","article-title":"Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY)","volume":"221","author":"Uccella","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102391_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/GMIT.GMIT_59_18","article-title":"Is it the time for laparoscopic management of early-stage ovarian malignancies?","volume":"7","author":"Tantitamit","year":"2018","journal-title":"Gynecol Minim Invasive Ther"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102391_bib39","doi-asserted-by":"crossref","first-page":"58.e1","DOI":"10.1016\/j.ajog.2013.04.013","article-title":"Staging laparoscopy for the management of early-stage ovarian cancer: a metaanalysis","volume":"209","author":"Park","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102391_bib40","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamaoncol.2020.1702","article-title":"Minimally invasive surgery and risk of capsule rupture for women with early stage ovarian cancer","volume":"6","author":"Matsuo","year":"2020","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2023.102391_bib41","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jmig.2022.04.014","article-title":"A\u00a0laparoscopic adjusted model able to predict the risk of intraoperative capsule rupture in early-stage ovarian cancer: laparoscopic ovarian cancer spillage score (LOChneSS study)","volume":"29","author":"Ghirardi","year":"2022","journal-title":"J\u00a0Minim Invasive Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102391_bib42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejso.2013.11.028","article-title":"Conservative treatment of early stage ovarian cancer: oncological and fertility outcomes","volume":"40","author":"Zapardiel","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102391_bib43","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2015.06.008","article-title":"Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of a international multicenter study comprising 545 patients","volume":"104","author":"Bentivegna","year":"2015","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102391_bib44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4293\/108680813X13654754535557","article-title":"Robotic-assisted fertility-sparing surgery for early ovarian cancer","volume":"18","author":"Finger","year":"2014","journal-title":"J\u00a0Soc Laparoendosc Surg"},{"issue":"8","key":"10.1016\/j.bpobgyn.2023.102391_bib45","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1245\/ASO.2006.08.021","article-title":"A\u00a0laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study","volume":"13","author":"Fagotti","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102391_bib46","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ygyno.2004.11.031","article-title":"Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study","volume":"96","author":"Fagotti","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2023.102391_bib47","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"9990","key":"10.1016\/j.bpobgyn.2023.102391_bib48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomized, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.01.017","article-title":"Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome","volume":"59","author":"Fagotti","year":"2016","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.bpobgyn.2023.102391_bib50","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/14737140.2016.1219658","article-title":"The role of minimally invasive interval debulking surgery in advanced epithelial ovarian cancer","volume":"16","author":"Menderes","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102391_bib51","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/AOG.0000000000001851","article-title":"Laparoscopy compared with laparotomy for debulking ovarian cancer after neoadjuvant chemotherapy","volume":"129","author":"Melamed","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102391_bib52","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/IGC.0000000000000491","article-title":"Laparoscopic debulking surgery in the management of advanced ovarian cancer after neoadjuvant chemotherapy","volume":"25","author":"Corrado","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102391_bib53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000381462","article-title":"Oncologic concerns regarding laparoscopic cytoreductive surgery in patients with advanced ovarian cancer submitted to neoadjuvant chemotherapy","volume":"89","author":"Favero","year":"2015","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102391_bib54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/ijgc-2018-000012","article-title":"The International Mission Study: minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapy","volume":"29","author":"Fagotti","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102391_bib55","doi-asserted-by":"crossref","first-page":"503.e1","DOI":"10.1016\/j.ajog.2015.10.922","article-title":"Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial\u2013NCT02324595): a feasibility study","volume":"214","author":"Gueli Alletti","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102391_bib56","first-page":"245","article-title":"Interval robotic cytoreduction following neoadjuvant chemotherapy in advanced ovarian cancer","volume":"12","author":"Ackroyd","year":"2018","journal-title":"J\u00a0Robot Surg"},{"issue":"15","key":"10.1016\/j.bpobgyn.2023.102391_bib57","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.3390\/cancers14153579","article-title":"Does MIS play a role in the treatment of advanced ovarian cancer?","volume":"14","author":"Pereira","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102391_bib58","first-page":"155","article-title":"Robotic interval debulking surgery for advanced epithelial ovarian cancer: current challenge or future direction? A systematic review","volume":"15","author":"Psomiadou","year":"2021","journal-title":"J\u00a0Robot Surg"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102391_bib59","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jmig.2020.11.015","article-title":"Comparing laparotomy with robot-assisted interval debulking surgery for patients with advanced epithelial ovarian cancer receiving neoadjuvant chemotherapy","volume":"28","author":"Zhang","year":"2021","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejogrb.2022.11.005","article-title":"Robotic surgery in early and advanced ovarian cancer: case selection for surgical staging and interval debulking surgery","volume":"280","author":"Van Trappen","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102391_bib61","first-page":"4","article-title":"Feasibility and safety of minimally invasive technology for interval cytoreductive surgery during advanced ovarian cancer after neoadjuvant chemotherapy","volume":"43","author":"Yang","year":"2022","journal-title":"Eur J Gynaecol Oncol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102391_bib62","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/bjc.2012.307","article-title":"Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients","volume":"107","author":"Wagner","year":"2012","journal-title":"Br J Cancer"},{"issue":"29","key":"10.1016\/j.bpobgyn.2023.102391_bib63","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1200\/JCO.2006.06.0913","article-title":"Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG","volume":"24","author":"Pfisterer","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102391_bib64","first-page":"189","article-title":"Survival of patients following secondary cytoreductive surgery in ovarian cancer","volume":"61","author":"Berek","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib65","article-title":"The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients","volume":"30","author":"So","year":"2019","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib66","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/IGC.0000000000000598","article-title":"Surgery for recurrent epithelial ovarian cancer in The Netherlands: a population-based cohort study","volume":"26","author":"van de Laar","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.06.009","article-title":"Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer","volume":"221","author":"Gockley","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib68","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib69","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ygyno.2017.02.010","article-title":"A\u00a0comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer","volume":"145","author":"Cowan","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib70","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2014.09.017","article-title":"Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial","volume":"136","author":"Lee","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"23","key":"10.1016\/j.bpobgyn.2023.102391_bib71","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa2103294","article-title":"Randomized trial of cytoreductive surgery for relapsed ovarian cancer","volume":"385","author":"Harter","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib72","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ejso.2018.08.006","article-title":"Minimally invasive salvage lymphadenectomy in gynecological cancer patients: a single institution series","volume":"44","author":"Gallotta","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib73","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jmig.2017.10.024","article-title":"Secondary laparoscopic cytoreduction in recurrent ovarian cancer: a large, single-institution experience","volume":"25","author":"Gallotta","year":"2018","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib74","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00464-013-3390-9","article-title":"Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience","volume":"28","author":"Gallotta","year":"2014","journal-title":"Surg Endosc"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib75","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jso.25335","article-title":"The role of robotic aortic lymphadenectomy in gynecological cancer: surgical and oncological outcome in a single institution experience","volume":"119","author":"Gallotta","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib76","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jmig.2016.01.029","article-title":"Laparoscopic management of ovarian cancer patients with localized carcinomatosis and lymph node metastases: results of a retrospective multi-institutional series","volume":"23","author":"Gallotta","year":"2016","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib77","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jmig.2018.01.007","article-title":"Robotic surgery in elderly and very elderly gynecologic cancer patients","volume":"25","author":"Gallotta","year":"2018","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib78","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2013.01.015","article-title":"Analysis of secondary cytoreduction for recurrent ovarian cancer by robotics, laparoscopy and laparotomy","volume":"129","author":"Magrina","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib79","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2017.05.022","article-title":"Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: perioperative and oncologic outcomes","volume":"146","author":"Eriksson","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib80","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ygyno.2014.05.007","article-title":"Feasibility and perioperative outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer: a multi-institutional study","volume":"134","author":"Escobar","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib81","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.ejso.2020.01.035","article-title":"Salvage lymphadenectomy in recurrent ovarian cancer patients: analysis of clinical outcome and BRCA1\/2 gene mutational status","volume":"46","author":"Gallotta","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2022-003904","article-title":"The role of minimally invasive secondary cytoreduction in recurrent ovarian cancer patients","author":"Conte","year":"2023","journal-title":"Accepted on Int j gynecol cancer"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib83","article-title":"Association between overall survival and the tendency for cancer programs to administer neoadjuvant chemotherapy for patients with advanced ovarian cancer [published online ahead of print, 2021 Sep 30]","author":"Melamed","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib84","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study","volume":"22","author":"Spiliotis","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib85","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/IGC.0000000000000864","article-title":"Brief report about the role of hyperthermic intraperitoneal chemotherapy in a prospective randomized phase 3 study in recurrent ovarian cancer from Spiliotis et\u00a0al","volume":"27","author":"Harter","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib86","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018355","article-title":"Selection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.bpobgyn.2023.102391_bib87","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ygyno.2012.09.020","article-title":"Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two year follow-up","volume":"127","author":"Fagotti","year":"2012","journal-title":"Gynecol Oncol"}],"updated-by":[{"DOI":"10.1016\/j.bpobgyn.2023.102419","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000}}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693423000998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693423000998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T16:19:45Z","timestamp":1696349985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693423000998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":85,"alternative-id":["S1521693423000998"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2023.102391","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bpobgyn.2023.102419","asserted-by":"object"}]},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Robotic surgery in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2023.102391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102391"}}